1. Home
  2. LSTR vs PRAX Comparison

LSTR vs PRAX Comparison

Compare LSTR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landstar System Inc.

LSTR

Landstar System Inc.

HOLD

Current Price

$212.69

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$319.63

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTR
PRAX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
LSTR
PRAX
Price
$212.69
$319.63
Analyst Decision
Hold
Strong Buy
Analyst Count
12
15
Target Price
$173.83
$572.13
AVG Volume (30 Days)
404.5K
514.9K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$4,743,760,000.00
N/A
Revenue This Year
$6.89
N/A
Revenue Next Year
$9.05
$7,758.26
P/E Ratio
$182.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$119.40
$37.25
52 Week High
$228.46
$366.52

Technical Indicators

Market Signals
Indicator
LSTR
PRAX
Relative Strength Index (RSI) 59.00 52.37
Support Level $202.41 $307.93
Resistance Level $214.80 $343.96
Average True Range (ATR) 5.44 19.22
MACD 0.14 -1.53
Stochastic Oscillator 83.76 46.73

Price Performance

Historical Comparison
LSTR
PRAX

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: